LDX lumos diagnostics holdings limited

LDX Chart, page-127

  1. 1,070 Posts.
    lightbulb Created with Sketch. 231
    LDX Equity Value before Product Revenue is around 18.6c or $82.6m market cap.

    This is before multiple stream future product revenue and a potential $2.5 billion USD annual healthcare cost saving in America alone if FebriDx was implemented for ARI (Acute Respiratory Infection) cases.

    Giddy Up LDX!!

    2277186_Economic-Evaluation-of-FebriDx.pdf (lumosdiagnostics.com)

    Economic Evaluation of FebriDx®: A Novel Rapid, Point-of-Care Test for Differentiation of Viral versus Bacterial Acute Respiratory Infection in the United States | Published in Journal of Health Economics and Outcomes Research (jheor.org)

    https://hotcopper.com.au/data/attachments/5513/5513284-99992dd34aa5430252a502fe21880836.jpg





 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
7.2¢
Change
0.004(5.88%)
Mkt cap ! $53.89M
Open High Low Value Volume
7.1¢ 7.4¢ 6.9¢ $516.9K 7.209M

Buyers (Bids)

No. Vol. Price($)
2 301427 7.0¢
 

Sellers (Offers)

Price($) Vol. No.
7.2¢ 361833 3
View Market Depth
Last trade - 16.15pm 25/07/2025 (20 minute delay) ?
LDX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.